John Walker

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Oncology Dept

Email: jwwalker@ualberta.ca

Overview

Area of Study / Keywords

About

Walker is certified by the Royal College of Physicians and Surgeons of Canada as a specialist in Internal Medicine with subspecialty training in Medical Oncology. He has been a Medical Oncologist at the Cross Cancer Institute since 2013.

Research

Oncologic care of patients with malignant melanoma
Phase III clinical trials and outcomes research?

Featured Publications

PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma

Joseph K., Walker J., Raziee H., Faruqi S., Smylie M.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY. 2022 May; 26 (3):243-248 10.1177/12034754211064273

Rapid Unmasking of Immune-related Adverse Events after Discontinuation of Chemotherapy in Chemo-immunotherapy Regimens

Riopel N.D., Chu Q., Walker J., Ye C.

JOURNAL OF IMMUNOTHERAPY. 2022 May; 45 (4):207-209 10.1097/CJI.0000000000000409

Fracture Rate Increases after Immune Checkpoint Inhibition: A Possible New Immune-related Adverse Event

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. 2022 March;

Patterns and predictors of relapse in Merkel cell carcinoma: Results from a population-based study

Joseph K., Wong J., Abraham A., Zebak J., Patel A., Jones Thachuthara A., Iqbal U., Pham T.M., Menon A., Ghosh S., Warkentin H., Walker J., Jha N., Faruqi S., Salopek T.G., Smylie M.

RADIOTHERAPY AND ONCOLOGY. 2022 January; 166 10.1016/j.radonc.2021.11.015

Myosteatosis is prognostic in metastatic melanoma treated with nivolumab

Youn S., Reif R., Chu M.P., Smylie M., Walker J., Eurich D.T., Ghosh S., Sawyer M.B.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE. 2021 April; 42 10.1016/j.clnesp.2021.01.009

The quality of sars-cov-2-specific t cell functions differs in patients with mild/moderate versus severe disease, and t cells expressing coinhibitory receptors are highly activated

Shahbaz S., Xu L., Sligl W., Osman M., Bozorgmehr N., Mashhouri S., Redmond D., Rosero E.P., Walker J., Elahi S.

JOURNAL OF IMMUNOLOGY. 2021 March; 207 (4):1099-1111 10.4049/jimmunol.2100446

Metastatic melanoma refractory to immune-checkpoint inhibitors: can radiotherapy improve the response?

Canadian Association of Radiation Oncology (CARO) Annual Scientific Meeting. 2021 February;

Response and Toxicity patterns seen in Patients Treated with Combination Immunotherapy and Radiotherapy in the UNSCARRed (UNresectable Squamous Cell Carcinoma treated with Avelumab and Radical Radiotherapy)

Canadian Association of Radiation Oncology Annual Scientific Meeting. 2021 February; n/a

Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors

Zwald F., Carvajal R.D., Walker J., Sawinski D., Al-Adra D.

Clinical Transplantation. 2021 January; 35 (5) 10.1111/ctr.14264

Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors

Okoye I., Xu L., Motamedi M., Parashar P., Walker J.W., Elahi S.

Journal for ImmunoTherapy of Cancer. 2020 December; 8 (2) 10.1136/jitc-2020-001849